Boston Scientific Corporation
BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardiovā¦ read more
Healthcare
Medical Devices
33 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$69.13
Price+0.84%
$0.57
1Y
Price
Market Cap
$102.581b
Large
Price/Earnings 3y Avg5y Avg
35.6x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+18.1%
EBITDA Margin+12.6%
Net Profit Margin+19.2%
Free Cash Flow Margin+18.1%
EBITDA Margin+12.6%
Net Profit Margin+19.2%
Free Cash Flow MarginRevenue
$20.074b
+19.9%
1y CAGR+16.6%
3y CAGR+14.1%
5y CAGREarnings
$2.886b
+55.9%
1y CAGR+66.8%
3y CAGR+41.9%
5y CAGREPS
$1.94
+54.4%
1y CAGR+69.7%
3y CAGR+43.6%
5y CAGRBook Value
$24.472b
$43.673b
Assets$19.201b
Liabilities$12.418b
DebtDebt to Assets
28.4%
2.5x
Debt to EBITDAFree Cash Flow
$3.658b
+37.1%
1y CAGR+59.6%
3y CAGR+37.0%
5y CAGRNo items found.
Press Releases
Statements and updates from the company